Exopolysaccharide from Lactobacillus rhamnosus ZFM231 alleviates DSS-induced colitis in mice by regulating gut microbiota.
- 2022-07-02
- Clinical Trial
- Journal of the Science of Food and Agriculture 102(15)
- C. Wan
- Wen-Wen Qian
- W. Liu
- X. Pi
- Meng Tang
- Xiao-Lin Wang
- Q. Gu
- Ping Li
- Tao Zhou
- PubMed: 35707876
- DOI: 10.1002/jsfa.12070
- Low evidence
- Rigorous Journal
- Animal Study
- Clinical
Compared with the model group, in the EPS-treated group, the diversity of and the composition of gut microbiota at both phylum and genus levels were found to recover to the levels of normal group, indicating the effective modulation on gut microbiota by EPS.
- Effect
- Beneficial
- Effect size
- Large